119 related articles for article (PubMed ID: 16338950)
1. AmpC beta-lactamase-mediated cefpodoxime-resistant Escherichia coli isolated from faecal samples of healthy volunteers.
Kaneko K; Sato Y; Tokunaga SK; Tamaki SK; Okamoto R; Inoue M
J Antimicrob Chemother; 2006 Feb; 57(2):369-71. PubMed ID: 16338950
[No Abstract] [Full Text] [Related]
2. Activity of mecillinam against AmpC beta-lactamase-producing Escherichia coli.
Brenwald NP; Andrews J; Fraise AP
J Antimicrob Chemother; 2006 Jul; 58(1):223-4. PubMed ID: 16698846
[No Abstract] [Full Text] [Related]
3. Extended-spectrum-beta-lactamase-producing Escherichia coli strains isolated from farm animals from 1999 to 2002: report from the Japanese Veterinary Antimicrobial Resistance Monitoring Program.
Kojima A; Ishii Y; Ishihara K; Esaki H; Asai T; Oda C; Tamura Y; Takahashi T; Yamaguchi K
Antimicrob Agents Chemother; 2005 Aug; 49(8):3533-7. PubMed ID: 16048977
[TBL] [Abstract][Full Text] [Related]
4. [Investigation of plasmid-mediated AmpC beta-lactamase types in Klebsiella spp. and Escherichia coli isolates resistant or intermediate to cefoxitin].
Demirbakan H; Midilli K; Oğünç D; Ozen N; Ongüt G; Dağlar D; Mutlu D; Ozhak B; Colak D
Mikrobiyol Bul; 2008 Oct; 42(4):545-51. PubMed ID: 19149075
[TBL] [Abstract][Full Text] [Related]
5. High-level cefepime resistance in Escherichia coli from Singapore producing OXA-1 beta-lactamase.
Koh TH; Wang G; Koh TY
Int J Antimicrob Agents; 2008 Apr; 31(4):382-3. PubMed ID: 18178066
[No Abstract] [Full Text] [Related]
6. First description of an oxyimino-cephalosporin-resistant, ESBL-carrying Escherichia coli isolated from meat sold in Denmark.
Jensen LB; Hasman H; Agersø Y; Emborg HD; Aarestrup FM
J Antimicrob Chemother; 2006 Apr; 57(4):793-4. PubMed ID: 16504999
[No Abstract] [Full Text] [Related]
7. [Expression of high-level cephalosporinase due to mutation in the AmpC attenuator of a clinical Escherichia coli strain].
Guan XZ; Liu YN; Luo YP; She DY; Lu SJ; Zhou G; Chen LA
Zhonghua Yi Xue Za Zhi; 2006 Mar; 86(9):600-4. PubMed ID: 16681904
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of extended-spectrum beta-lactamase-producing Escherichia coli isolates in faecal samples of broilers.
Costa D; Vinué L; Poeta P; Coelho AC; Matos M; Sáenz Y; Somalo S; Zarazaga M; Rodrigues J; Torres C
Vet Microbiol; 2009 Sep; 138(3-4):339-44. PubMed ID: 19372011
[TBL] [Abstract][Full Text] [Related]
9. Prevalent phenotypes and antibiotic resistance in Escherichia coli and Klebsiella pneumoniae at an Indian tertiary care hospital: plasmid-mediated cefoxitin resistance.
Shahid M; Malik A; Akram M; Agrawal LM; Khan AU; Agrawal M
Int J Infect Dis; 2008 May; 12(3):256-64. PubMed ID: 17981482
[TBL] [Abstract][Full Text] [Related]
10. Characterization of TEM-, SHV- and AmpC-type beta-lactamases from cephalosporin-resistant Enterobacteriaceae isolated from swine.
Rayamajhi N; Kang SG; Lee DY; Kang ML; Lee SI; Park KY; Lee HS; Yoo HS
Int J Food Microbiol; 2008 May; 124(2):183-7. PubMed ID: 18455821
[TBL] [Abstract][Full Text] [Related]
11. Extended-spectrum and AmpC beta-lactamases in Escherichia coli and Klebsiella pneumoniae from a rural South Indian tertiary care hospital.
Navaneeth BV
Int J Antimicrob Agents; 2007 May; 29(5):602-3. PubMed ID: 17296286
[No Abstract] [Full Text] [Related]
12. Extension of the hydrolysis spectrum of AmpC beta-lactamase of Escherichia coli due to amino acid insertion in the H-10 helix.
Mammeri H; Poirel L; Nordmann P
J Antimicrob Chemother; 2007 Sep; 60(3):490-4. PubMed ID: 17586561
[TBL] [Abstract][Full Text] [Related]
13. In vivo selection of an Escherichia coli isolate highly resistant to ciprofloxacin and ceftazidime: role of a 4-bp duplication in acrR and ampC overexpression.
Corvec S; Lepelletier D; Reynaud A; Dauvergne S; Giraudeau C; Caroff N
Int J Antimicrob Agents; 2008 Aug; 32(2):196-8. PubMed ID: 18571906
[No Abstract] [Full Text] [Related]
14. In vitro activity, beta-lactamase stability and PBP affinity of RU 51,746-2, the active metabolite of the new orally absorbed cephalosporin ester, RU 51807.
Boaretti M; Lleó MM; Canepari P
J Chemother; 1991 Jan; 3 Suppl 1():57-61. PubMed ID: 12041787
[TBL] [Abstract][Full Text] [Related]
15. Characteristics of extended-spectrum cephalosporin-resistant Escherichia coli and Klebsiella pneumoniae isolates from horses.
Vo AT; van Duijkeren E; Fluit AC; Gaastra W
Vet Microbiol; 2007 Oct; 124(3-4):248-55. PubMed ID: 17521833
[TBL] [Abstract][Full Text] [Related]
16. Contribution of extended-spectrum AmpC (ESAC) beta-lactamases to carbapenem resistance in Escherichia coli.
Mammeri H; Nordmann P; Berkani A; Eb F
FEMS Microbiol Lett; 2008 May; 282(2):238-40. PubMed ID: 18371063
[TBL] [Abstract][Full Text] [Related]
17. Genetic detection of extended-spectrum beta-lactamase-containing Escherichia coli isolates and vancomycin-resistant enterococci in fecal samples of healthy children.
Guimarães B; Barreto A; Radhouani H; Figueiredo N; Gaspar E; Rodrigues J; Torres C; Igrejas G; Poeta P
Microb Drug Resist; 2009 Sep; 15(3):211-6. PubMed ID: 19728780
[TBL] [Abstract][Full Text] [Related]
18. Interplay of efflux, impermeability, and AmpC activity contributes to cefuroxime resistance in clinical, non-ESBL-producing isolates of Escherichia coli.
Källman O; Giske CG; Samuelsen Ø; Wretlind B; Kalin M; Olsson-Liljequist B
Microb Drug Resist; 2009 Jun; 15(2):91-5. PubMed ID: 19432520
[TBL] [Abstract][Full Text] [Related]
19. Detection and characterisation of CTX-M and CMY-2 beta-lactamases among Escherichia coli isolates from farm animals in Guangdong Province of China.
Liu JH; Wei SY; Ma JY; Zeng ZL; Lü DH; Yang GX; Chen ZL
Int J Antimicrob Agents; 2007 May; 29(5):576-81. PubMed ID: 17314033
[TBL] [Abstract][Full Text] [Related]
20. Emergence of imipenem resistance in clinical Escherichia coli during therapy.
Oteo J; Delgado-Iribarren A; Vega D; Bautista V; Rodríguez MC; Velasco M; Saavedra JM; Pérez-Vázquez M; García-Cobos S; Martínez-Martínez L; Campos J
Int J Antimicrob Agents; 2008 Dec; 32(6):534-7. PubMed ID: 18775649
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
